1. At a Glance – Blink and You’ll Miss the Scale
Syrma SGS is no longer that “nice EMS company with potential.” As of Q3 FY26, it’s a ₹13,963 Cr market cap beast trading around ₹724, delivering ₹12,745 mn quarterly revenue and ₹1,103 mn PAT, up 108% YoY. Stock P/E sits at ~49, EV/EBITDA at ~26, ROCE 11.7%, ROE 9.45%, and debt remains polite at ₹332 Cr. The last 3 months? The stock sulked (-11%), while the business sprinted. That disconnect is where curiosity begins. Is the market sleepy, or is Syrma quietly compounding behind the factory gates?
2. Introduction – From “Make in India” Slogan to Spreadsheet Reality
EMS companies love buzzwords—localisation, backward integration, PLI, China+1. Syrma SGS has been chanting these for years. The difference now? Numbers finally agree. Q3 FY26 shows operating leverage in action: margins expanding, profits exploding, and order books refusing to shrink. Yet, ROE remains underwhelming, working capital is chunky, and valuation already assumes future greatness. So this isn’t a fairy tale—it’s a test of execution vs expectations. Ready to see if Syrma is an operator or a storyteller?
3. Business Model – WTF Do They Even Do?
In simple terms: Syrma designs, engineers, assembles, tests, and ships electronics so OEMs can sleep peacefully.
They handle:
